伊利(600887.SH)登「胡潤中國民營企業可持續發展百強榜」首位
胡潤研究院發布《2021胡潤中國民營企業可持續發展百強榜》,列出了100家最符合聯合國17個可持續發展目標的中國民營企業。伊利(600887.SH)登榜首,華為和碧桂園(02007.HK)分別排第二和第三。海爾智家(06690.HK)、中國平安(02318.HK)和復星國際(00656.HK)並列第四。阿里(09988.HK)排第七、比亞迪(01211.HK)及騰訊(00700.HK)並列第八。
以藥明康德(02359.HK)為代表的醫藥保健行業企業進入百強最多,有13家;其次是以阿里巴巴、騰訊為代表的大眾網絡服務行業,有10家。
以比亞迪、長城汽車(02333.HK)為代表的汽車行業,和以碧桂園、世茂(00813.HK)為代表的房地產行業各有7家企業進入百強。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.